REDUCEDT+30
Oramed Pharmaceuticals Inc · NASDAQ
−20,000 sh · $90.2K
Filed 2 Oct 2026SEC Form 4view source
- ACQUIREDT+30
Oramed Pharmaceuticals Inc · NASDAQ
+209,291 sh
Filed 25 Sept 2026SEC Form 4view source - ACQUIREDStale
Lifeward Ltd · NASDAQ
+13,643 sh
Filed 24 Aug 2026SEC Form 4view source